U-91939

N/A

Report date: 2022/02/14 11:17:09
NME

Base Information

Drug NameU-91939
Drug Alias NameU-91939U-91939E
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase IV inhibitors
TargetsDNA topoisomeraseTopoisomerase IV
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A